Cost-Effectiveness Of Ra Biologics In The Two Years Following Initiation Using A Validated Claims-Based Algorithm In A United States Commercially Insured Population
May 1, 2014, 00:00
10.1016/j.jval.2014.03.278
https://www.valueinhealthjournal.com/article/S1098-3015(14)00329-5/fulltext
Title :
Cost-Effectiveness Of Ra Biologics In The Two Years Following Initiation Using A Validated Claims-Based Algorithm In A United States Commercially Insured Population
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00329-5&doi=10.1016/j.jval.2014.03.278
First page :
A46
Section Title :
Muscular-Skeletal Disorders
Open access? :
No
Section Order :
1314